Similarly, colorectal cancer patients with high expression of CRIP2, PRAM1, HSPB2 or CERCAM had poorer OS comparing with low expressed groups (logrank = 0.0073, 0.0053, 0.0036 and 0.0023, respectively). This evidence concerns the gene PRAM1 and colorectal cancer.